HIV eradication symposium: will the brain be left behind?

B. J. Brew, K. Robertson, E. J. Wright, M. Churchill, S. M. Crowe, L. A. Cysique, S. Deeks, J. V. Garcia, Benjamin Gelman, L. R. Gray, T. Johnson, J. Joseph, D. M. Margolis, J. L. Mankowski, B. Spencer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

On 18 July 2014, the National Institute of Mental Health in collaboration with ViiV Health Care and Boehringer Ingelheim supported a symposium on HIV eradication and what it meant for the brain. The symposium was an affiliated event to the 20th International AIDS Conference. The meeting was held in Melbourne, Australia, and brought together investigators currently working on HIV eradication together with investigators who are working on the neurological complications of HIV. The purpose of the meeting was to bring the two fields of HIV eradication and HIV neurology together to foster dialogue and cross talk to move the eradication field forward in the context of issues relating to the brain as a potential reservoir of HIV. The outcomes of the symposium were that there was substantive but not definitive evidence for the brain as an HIV reservoir that will provide a challenge to HIV eradication. Secondly, the brain as a clinically significant reservoir for HIV is not necessarily present in all patients. Consequently, there is an urgent need for the development of biomarkers to identify and quantify the HIV reservoir in the brain. Lastly, when designing and developing eradication strategies, it is critical that approaches to target the brain reservoir be included.

Original languageEnglish (US)
Pages (from-to)322-334
Number of pages13
JournalJournal of NeuroVirology
Volume21
Issue number3
DOIs
StatePublished - Jun 16 2015
Externally publishedYes

Fingerprint

HIV
Brain
Research Personnel
National Institute of Mental Health (U.S.)
Neurology
Acquired Immunodeficiency Syndrome
Biomarkers
Delivery of Health Care

Keywords

  • Acquired immunodeficiency syndrome
  • Brain
  • Eradication
  • HIV-associated neurocognitive disorders
  • Human immunodeficiency virus type 1

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Neurology

Cite this

Brew, B. J., Robertson, K., Wright, E. J., Churchill, M., Crowe, S. M., Cysique, L. A., ... Spencer, B. (2015). HIV eradication symposium: will the brain be left behind? Journal of NeuroVirology, 21(3), 322-334. https://doi.org/10.1007/s13365-015-0322-6

HIV eradication symposium : will the brain be left behind? / Brew, B. J.; Robertson, K.; Wright, E. J.; Churchill, M.; Crowe, S. M.; Cysique, L. A.; Deeks, S.; Garcia, J. V.; Gelman, Benjamin; Gray, L. R.; Johnson, T.; Joseph, J.; Margolis, D. M.; Mankowski, J. L.; Spencer, B.

In: Journal of NeuroVirology, Vol. 21, No. 3, 16.06.2015, p. 322-334.

Research output: Contribution to journalArticle

Brew, BJ, Robertson, K, Wright, EJ, Churchill, M, Crowe, SM, Cysique, LA, Deeks, S, Garcia, JV, Gelman, B, Gray, LR, Johnson, T, Joseph, J, Margolis, DM, Mankowski, JL & Spencer, B 2015, 'HIV eradication symposium: will the brain be left behind?', Journal of NeuroVirology, vol. 21, no. 3, pp. 322-334. https://doi.org/10.1007/s13365-015-0322-6
Brew BJ, Robertson K, Wright EJ, Churchill M, Crowe SM, Cysique LA et al. HIV eradication symposium: will the brain be left behind? Journal of NeuroVirology. 2015 Jun 16;21(3):322-334. https://doi.org/10.1007/s13365-015-0322-6
Brew, B. J. ; Robertson, K. ; Wright, E. J. ; Churchill, M. ; Crowe, S. M. ; Cysique, L. A. ; Deeks, S. ; Garcia, J. V. ; Gelman, Benjamin ; Gray, L. R. ; Johnson, T. ; Joseph, J. ; Margolis, D. M. ; Mankowski, J. L. ; Spencer, B. / HIV eradication symposium : will the brain be left behind?. In: Journal of NeuroVirology. 2015 ; Vol. 21, No. 3. pp. 322-334.
@article{b94e9a9eadf444df985479bcd880f718,
title = "HIV eradication symposium: will the brain be left behind?",
abstract = "On 18 July 2014, the National Institute of Mental Health in collaboration with ViiV Health Care and Boehringer Ingelheim supported a symposium on HIV eradication and what it meant for the brain. The symposium was an affiliated event to the 20th International AIDS Conference. The meeting was held in Melbourne, Australia, and brought together investigators currently working on HIV eradication together with investigators who are working on the neurological complications of HIV. The purpose of the meeting was to bring the two fields of HIV eradication and HIV neurology together to foster dialogue and cross talk to move the eradication field forward in the context of issues relating to the brain as a potential reservoir of HIV. The outcomes of the symposium were that there was substantive but not definitive evidence for the brain as an HIV reservoir that will provide a challenge to HIV eradication. Secondly, the brain as a clinically significant reservoir for HIV is not necessarily present in all patients. Consequently, there is an urgent need for the development of biomarkers to identify and quantify the HIV reservoir in the brain. Lastly, when designing and developing eradication strategies, it is critical that approaches to target the brain reservoir be included.",
keywords = "Acquired immunodeficiency syndrome, Brain, Eradication, HIV-associated neurocognitive disorders, Human immunodeficiency virus type 1",
author = "Brew, {B. J.} and K. Robertson and Wright, {E. J.} and M. Churchill and Crowe, {S. M.} and Cysique, {L. A.} and S. Deeks and Garcia, {J. V.} and Benjamin Gelman and Gray, {L. R.} and T. Johnson and J. Joseph and Margolis, {D. M.} and Mankowski, {J. L.} and B. Spencer",
year = "2015",
month = "6",
day = "16",
doi = "10.1007/s13365-015-0322-6",
language = "English (US)",
volume = "21",
pages = "322--334",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - HIV eradication symposium

T2 - will the brain be left behind?

AU - Brew, B. J.

AU - Robertson, K.

AU - Wright, E. J.

AU - Churchill, M.

AU - Crowe, S. M.

AU - Cysique, L. A.

AU - Deeks, S.

AU - Garcia, J. V.

AU - Gelman, Benjamin

AU - Gray, L. R.

AU - Johnson, T.

AU - Joseph, J.

AU - Margolis, D. M.

AU - Mankowski, J. L.

AU - Spencer, B.

PY - 2015/6/16

Y1 - 2015/6/16

N2 - On 18 July 2014, the National Institute of Mental Health in collaboration with ViiV Health Care and Boehringer Ingelheim supported a symposium on HIV eradication and what it meant for the brain. The symposium was an affiliated event to the 20th International AIDS Conference. The meeting was held in Melbourne, Australia, and brought together investigators currently working on HIV eradication together with investigators who are working on the neurological complications of HIV. The purpose of the meeting was to bring the two fields of HIV eradication and HIV neurology together to foster dialogue and cross talk to move the eradication field forward in the context of issues relating to the brain as a potential reservoir of HIV. The outcomes of the symposium were that there was substantive but not definitive evidence for the brain as an HIV reservoir that will provide a challenge to HIV eradication. Secondly, the brain as a clinically significant reservoir for HIV is not necessarily present in all patients. Consequently, there is an urgent need for the development of biomarkers to identify and quantify the HIV reservoir in the brain. Lastly, when designing and developing eradication strategies, it is critical that approaches to target the brain reservoir be included.

AB - On 18 July 2014, the National Institute of Mental Health in collaboration with ViiV Health Care and Boehringer Ingelheim supported a symposium on HIV eradication and what it meant for the brain. The symposium was an affiliated event to the 20th International AIDS Conference. The meeting was held in Melbourne, Australia, and brought together investigators currently working on HIV eradication together with investigators who are working on the neurological complications of HIV. The purpose of the meeting was to bring the two fields of HIV eradication and HIV neurology together to foster dialogue and cross talk to move the eradication field forward in the context of issues relating to the brain as a potential reservoir of HIV. The outcomes of the symposium were that there was substantive but not definitive evidence for the brain as an HIV reservoir that will provide a challenge to HIV eradication. Secondly, the brain as a clinically significant reservoir for HIV is not necessarily present in all patients. Consequently, there is an urgent need for the development of biomarkers to identify and quantify the HIV reservoir in the brain. Lastly, when designing and developing eradication strategies, it is critical that approaches to target the brain reservoir be included.

KW - Acquired immunodeficiency syndrome

KW - Brain

KW - Eradication

KW - HIV-associated neurocognitive disorders

KW - Human immunodeficiency virus type 1

UR - http://www.scopus.com/inward/record.url?scp=84939970909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939970909&partnerID=8YFLogxK

U2 - 10.1007/s13365-015-0322-6

DO - 10.1007/s13365-015-0322-6

M3 - Article

C2 - 25750070

AN - SCOPUS:84939970909

VL - 21

SP - 322

EP - 334

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 3

ER -